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Evaluation of the Vitek MS Matrix-Assisted Laser Desorption
Ionization–Time of Flight Mass Spectrometry System for Identification
of Clinically Relevant Filamentous Fungi
Allison R. McMullen,a Meghan A. Wallace,a David H. Pincus,b Kathy Wilkey,b

Carey-Ann D. Burnhama

Invasive fungal infections have a high rate of morbidity and mortality, and accurate identification is necessary to guide appropriate antifungal therapy. With the increasing incidence of invasive disease attributed to filamentous fungi, rapid and accurate species-level identification of these pathogens is necessary. Traditional methods for identification of filamentous fungi can be slow
and may lack resolution. Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has
emerged as a rapid and accurate method for identification of bacteria and yeasts, but a paucity of data exists on the performance
characteristics of this method for identification of filamentous fungi. The objective of our study was to evaluate the accuracy of
the Vitek MS for mold identification. A total of 319 mold isolates representing 43 genera recovered from clinical specimens were
evaluated. Of these isolates, 213 (66.8%) were correctly identified using the Vitek MS Knowledge Base, version 3.0 database.
When a modified SARAMIS (Spectral Archive and Microbial Identification System) database was used to augment the version
3.0 Knowledge Base, 245 (76.8%) isolates were correctly identified. Unidentified isolates were subcultured for repeat testing; 71/
319 (22.3%) remained unidentified. Of the unidentified isolates, 69 were not in the database. Only 3 (0.9%) isolates were misidentified by MALDI-TOF MS (including Aspergillus amoenus [n ⴝ 2] and Aspergillus calidoustus [n ⴝ 1]) although 10 (3.1%) of
the original phenotypic identifications were not correct. In addition, this methodology was able to accurately identify 133/144
(93.6%) Aspergillus sp. isolates to the species level. MALDI-TOF MS has the potential to expedite mold identification, and misidentifications are rare.

F

ilamentous fungi are ubiquitous environmental microorganisms that have become increasingly important pathogens, especially in immunocompromised patients. Invasive fungal diseases have a high rate of morbidity and mortality, and accurate
identification is necessary to guide appropriate antifungal therapy. Traditionally, the identification of filamentous fungi has required the use of different phenotypic methods in conjunction
with macro- and microscopic assessment of the organism (1).
This process requires highly trained mycologists, and, in some
cases, turnaround time may be prolonged due to a requirement
for extended incubation periods, potentially delaying appropriate
therapy. Molecular methods, which can provide accurate identification to the species level, can be expensive, require specialized
equipment or expertise, and are not commonly available in clinical laboratories.
Matrix-assisted laser desorption ionization–time of flight mass
spectrometry (MALDI-TOF MS) has been utilized in the clinical
microbiology laboratory for rapid and accurate identification of
bacteria, mycobacteria, and yeasts (2–9). For filamentous fungi,
databases have been limited, and unlike bacteria, filamentous
fungi require additional processing steps to disrupt the cell wall,
extract proteins, and inactivate the isolate (10). These additional
processing steps and limited libraries have led laboratories to develop their own methodologies and databases to overcome these
barriers to adoption (11–13). These limitations have hindered
widespread implementation of this technology in the clinical laboratory for the identification of filamentous fungi.
Here, our objective was to evaluate the identification of filamentous fungi by the Vitek MS system with the Knowledge Base
version 3.0 database and SpectraIdentifier R2.1.0 software that is
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currently in development. This updated library contains 82
unique species from 31 different genera of filamentous fungi.
(This work was presented in part as a poster at the 114th General Meeting of the American Society for Microbiology, Boston,
MA, 17 to 20 May 2014 [14]).
MATERIALS AND METHODS
Clinical isolates. A total of 319 isolates of filamentous fungi representing
43 genera recovered from clinical samples submitted to the Barnes Jewish
Hospital microbiology laboratory were analyzed; these isolates were recovered between 2008 and 2014. Isolates were identified using standardof-care phenotypic characterization in the Barnes Jewish Hospital clinical
microbiology laboratory. For MALDI-TOF MS analysis, all isolates were
cultivated on Sabouraud dextrose agar (Remel, Lenexa, KS). Rapidly
growing species were tested after 2 to 3 days of incubation, and slowly
growing species were tested after 7 to 10 days of incubation at room
temperature.
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RESULTS

Correct identifications by Vitek MS. A total of 319 isolates of
filamentous fungi representing 43 genera were evaluated in this
study. Out of those isolates, 213 (66.8%) were correctly identified
using the Vitek MS Knowledge Base version 3.0 database and
SpectraIdentifier R2.1.0 software (Table 1). An additional 32 isolates were identified after analyses with our modified SARAMIS
database, for a total of 245 (76.8%) correct identifications. Eightysix percent (125/144) of Aspergillus species isolates were initially
identified, and eight more were correctly identified upon further
analyses with the SARAMIS software; 98.9% of Aspergillus flavus
and Aspergillus fumigatus, two common fungal pathogens within
this genus, were correctly identified (93/94 isolates). MALDI-TOF
MS was able to provide species-level identification for 13 Aspergillus species isolates which were identified only to the genus level
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using morphological characterization in the clinical laboratory
(Table 2). Four isolates required additional analyses with the
SARAMIS software. Only 17/26 (65%) Fusarium species isolates
were identified. For the Mucorales, only one out of the three Mucor
species isolates tested was identified and required the additional
SARAMIS analysis. Two-thirds (6/9) of the Rhizopus species isolates were correctly identified using the Knowledge Base version
3.0 database. The database also performed well for the correct
identification of the dimorphic fungi isolates, with 100% of the
Blastomyces dermatitidis (n ⫽ 4) and Histoplasma capsulatum (n ⫽
2) isolates identified. Of the dermatophytes tested, 100% of the
Trichophyton sp. (n ⫽ 12) and Microsporum sp. (n ⫽ 2) isolates
were correctly identified.
Misidentifications by Vitek MS. There were no misidentifications at genus level by the Vitek MS. At the species level, three
isolates were misidentified. Two isolates of Aspergillus amoenus
were identified as Aspergillus versicolor, and one isolate of Aspergillus calidoustus was identified as Aspergillus ustus.
Unidentified by Vitek MS. A total of 103 isolates were not
identified by Vitek MS using the Knowledge Base version 3.0 database (Table 1). When these isolates were further analyzed using
the modified SARAMIS database, the number of unidentified isolates was reduced to 71. These isolates were sequenced, and of the
71 unidentified isolates, only two isolates, A. fumigatus and Rhizopus microsporus, were included in the database.
Phenotypic identification errors. For isolates that were identified by phenotype and by Vitek MS, 10 discrepancies were observed (Table 3). This included isolates that were phenotypically
identified as A. fumigatus, Paecilomyces spp., Menispora spp., and
Chrysosporium spp. Sequencing results demonstrated that the Vitek MS system correctly identified all 10 isolates.
DISCUSSION

To our knowledge, this study represents the most comprehensive
evaluation of the Vitek MS and Knowledge Base version 3.0 library
for the identification of filamentous fungi. The majority of published
studies examining large study sets of filamentous fungi utilize the
Bruker Biotyper MALDI-TOF MS and the associated library and/or
laboratory-developed libraries (10, 11, 15–18). Prior studies have
evaluated the accuracy of MALDI-TOF MS for the identification of
only a few genera or groups of organisms, such as Aspergillus spp. or
the dermatophytes (12, 13, 19–26). In our study, which examined
319 isolates from 43 different genera, the Vitek MS version 3.0
library was able to correctly identify 66.8% of isolates and 76.8%
of the isolates after additional SARAMIS analysis.
Seventy-one isolates (22.3%) were not identified using the Vitek MS or the SARAMIS database although only two of the unidentified isolates were included in the database and could have
potentially been identified. These results are similar to those of
other studies with augmented databases, and our study challenges
the system with a larger number of genera in addition to an updated database and analysis software. Of note, in this investigation, there were no misidentifications at the genus level, and only
three isolates were incorrectly identified at the species level. Two
isolates, which were determined to be A. versicolor using sequencing, were identified as the closely related species A. amoenus by
MALDI-TOF analyses. A. amoenus and A. versicolor are both
members of the section Versicolores, and A. versicolor has been
shown to cause onychomycosis and, rarely, pneumonia (27–29).
A third isolate, A. calidoustus, was incorrectly identified as A. ustus
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Mold inactivation and extraction. Isolates were processed according
to the inactivation/extraction protocol for molds and Vitek MS identification (bioMérieux, Hazelwood, MO). In brief, hyphae and/or conidia
were collected with a moistened sterile cotton swab (Puritan Medial Products, Guilford, ME) from a 1- to 2-cm diameter of growth and inoculated
into 900 l of 70% ethanol (Sigma-Aldrich, St. Louis, MO) in a microcentrifuge tube. The suspension was vortexed for 3 to 5 s and centrifuged
at 10,000 ⫻ g for 2 min. The supernatant was discarded, and the pellet was
resuspended with 40 l of 70% formic acid (Sigma-Aldrich), followed by
the addition of 40 l of acetonitrile (Sigma-Aldrich). The suspension was
vortexed for 3 to 5 s and centrifuged again at 10,000 ⫻ g for 2 min. One
microliter of supernatant was transferred to the target slide. Once the
sample was dry, 1 l of matrix (␣-cyano-4-hydroxy-cinnamic acid; bioMérieux) was applied and allowed to dry prior to analysis. For each isolate, a single extraction was performed and spotted in duplicate. An Escherichia coli reference strain (ATCC 8739) was directly spotted and overlaid
with matrix on each acquisition group on each slide as a calibrant and
quality control per the manufacturer’s protocols.
MALDI-TOF MS analysis. Isolates were tested using the Vitek MS
system. Spectra obtained from the Vitek MS were analyzed using the
Knowledge Base, version 3.0 database and SpectraIdentifier R2.1.0 software. For data analysis, any Vitek MS identification and score reported
were acceptable. If no identification was obtained, the isolate was repeated. Repeat testing consisted of resubbing the isolate, incubating it for
the desired length of time, and repeating the inactivation and extraction
procedure. If an isolate did not yield identification upon repeat testing, it
was labeled as “no identification.”
Evaluating spectra. Isolates that remained unidentified upon repeat
of the MALDI-TOF MS analysis were further analyzed using the SARAMIS (Spectral Archive and Microbial Identification System) database. Isolates that were related to isolates previously identified or that had been
sent for sequencing were compared to spectra in the database. Isolate
spectra were grouped together in a taxonomy tree using the SARAMIS,
version 4.12, software/analysis tool. Isolates that clustered with a relative
taxonomy of approximately ⱖ65% were considered related at the species
level. Outliers were removed from the taxonomy tree, and a superspectrum was created with the remaining isolate spectra. Superspectra added
to the database were used for future isolate identification.
Sequencing. Isolates that had discrepant phenotypic identification
compared to the MALDI-TOF MS identification and unidentified isolates
were sent to the Fungus Testing Laboratory at the University of Texas
Health Science Center (San Antonio, TX). Gene targets for sequencing
were chosen based on the presumptive species identification by morphological characteristics. For the majority of the isolates, the internal transcribed spacer region 1/2 (ITS1/2) was sequenced; this was augmented
with D1/D2 (domain of 26S), beta-tubulin (TUB), elongation factor
(TEF), actin (ACT), or glyceraldehyde-3-phosphate dehydrogenase
(GPD), as appropriate for the taxa being evaluated.

McMullen et al.

TABLE 1 Performance of the Vitek MS version 3.0 library for the identification of filamentous fungi
No. (%) of isolates
Identified by Knowledge Base
version 3.0 plus modified
SARAMIS database

Total

Unidentified

Misidentified

Acrodontium salmoneum
Alternaria spp.

1
11

0 (0.0)
10 (90.9)

0 (0.0)
11 (100)

1
0

0
0

Aspergillus spp.
A. amoenus
A. calidoustus
A. carneus
A. chevalieri
A. clavatus
A. flavus
A. fumigatus
A. lentulus
A. nidulans
A. niger
A. sydowii
A. tennesseensis
A. terreus
A. unguis
A. westerdijkiae

144
2
1
1
1
2
31
63
2
1
22
5
1
8
1
3

125 (86.8)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
28 (90.3)
61 (96.8)
2 (100.0)
1 (100.0)
19 (86.3)
5 (100.0)
0 (0.0)
8 (100.0)
1 (100.0)
0 (0.0)

133 (93.6)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
1 (50.0)
31 (100.0)
62 (98.9)
2 (100.0)
1 (100.0)
22 (100)
5 (100.0)
0 (0.0)
8 (100.0)
1 (100.0)
0 (0.0)

8
0
0
1
1
1
0
1
0
0
0
0
1
0
0
3

3
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0

Beauveria spp.
Bipolaris spp.
Blastomyces dermatitidis
Chaetomium spp.
Chrysosporium spp.
Cladosporium spp.
Coniochaeta velutina
Coprinellus radians
Coprinopsis cinerea (Hormographiella)
Curvularia spp.
Engyodontium album
Eutypella scoparia
Exophiala spp.
Fusarium spp.
Ganoderma resinaceum
Histoplasma capsulatum
Irpex lacteus
Libertella spp.
Malbranchea filamentosa
Microsporum spp.
Mucor spp.
Myrmecridium schulzeri
Neurospora sitophila
Nodulisporium spp.
Oxyporus corticola
Paecilomyces spp.
Paraconiothyrium brasiliense
Penicillium spp.
Phialemonium obovatum
Phialophora americana
Pithomyces chartarum
Pseudallescheria boydii
Rasamsonia argillacea complex
Rhizopus spp.
Scopulariopsis spp.
Talaromyces spp.
Trametes spp.
Trichoderma spp.

1
2
4
1
2
12
1
1
1
5
1
3
2
26
1
2
1
4
1
2
3
2
1
1
1
4
1
20
1
1
3
10
4
9
6
2
5
3

0 (0.0)
2 (100.0)
4 (100.0)
0 (0.0)
0 (0.0)
2 (16.7)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
3 (100.0)
0 (0.0)
17 (65.4)
0 (0.0)
2 (100.0)
0 (0.0)
0 (0.0)
0 (0.0)
2 (100.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
4 (100.0)
0 (0.0)
12 (60.0)
0 (0.0)
0 (0.0)
0 (0.0)
9 (90.0)
3 (75.0)
6 (66.7)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)

0 (0.0)
2 (100.0)
4 (100.0)
0 (0.0)
1 (50.0)
10 (83.3)
0 (0.0)
0 (0.0)
0 (0.0)
3 (60.0)
0 (0.0)
3 (100.0)
0 (0.0)
17 (65.4)
0 (0.0)
2 (100.0)
0 (0.0)
2 (50.0)
0 (0.0)
2 (100.0)
1 (33.3)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
4 (100.0)
0 (0.0)
12 (60.0)
0 (0.0)
0 (0.0)
0 (0.0)
10 (100.0)
4 (100.0)
6 (66.7)
4 (66.7)
0 (0.0)
2 (40.0)
0 (0.0)

1
0
0
1
1
2
1
1
1
2
1
0
2
9
1
0
1
2
1
0
2
2
1
1
1
0
1
8
1
1
3
0
0
3
2
2
3
3

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Trichophyton spp.
T. interdigitale
T. rubrum
T. tonsurans

12
5
2
5

12 (100.0)
5 (100.0)
2 (100.0)
5 (100.0)

12 (100.0)
5 (100.0)
2 (100.0)
5 (100.0)

0
0
0
0

0
0
0
0

Xylomelasma sordida

1

0 (0.0)

0 (0.0)

1

0

Total

319

213 (66.8)

245 (76.8)

71 (22.3)

3 (0.9)

by MALDI-TOF MS. These two species are closely related, and
previous studies have shown that most, if not all, clinical isolates of
A. calidoustus were previously misidentified as A. ustus. The ability
to correctly identify A. calidoustus in the clinical lab is important
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due to its resistance to multiple antifungals, including azoles (30,
31). However, the misidentifications encountered in this investigation are unlikely to be clinically significant as a result of the
similarity of these species.
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Organism

Identified by Knowledge
Base version 3.0

MALDI-TOF MS for Identiﬁcation of Filamentous Fungi

TABLE 2 Species-level identification of Aspergillus sp. isolates by
MALDI-TOF MS
Identified only to genus
level by clinical lab (no.
of isolates)

A. flavus/A. oryzae
A. fumigatus
A. nidulans
A. sydowii
A. terreus
A. unguis

2
2
1
4
3
1

Phenotypic identification
(n)a

MALDI-TOF MS
identification

Sequencing
identification

Aspergillus fumigatus (2)
Menispora spp. (2)
Paecilomyces spp. (1)
Paecilomyces spp. (4)

Aspergillus lentulus
Eutypella scoparia
Aspergillus sydowii
Rasamsonia argillacea
complex
Pseudallescheria
boydii

Aspergillus lentulus
Eutypella scoparia
Aspergillus sydowii
Rasamsonia argillacea
complex
Pseudallescheria
boydii

Chrysosporium spp. (1)
a

Identification using MALDI-TOF MS may overcome the difficulties with traditional identification methods, especially with
sterile molds and species that are morphologically similar but may
differ genetically. Using MALDI-TOF MS, we were able to identify
13 different Aspergillus spp. that were identified only to the genus
level using routine phenotypic identification in the clinical laboratory. Additionally, our study demonstrated that there were 10
isolates incorrectly identified using traditional phenotypic methods. This represents just over 3% of all isolates examined in this
study. Two isolates identified as A. fumigatus were confirmed to be
Aspergillus lentulus by both MALDI-TOF MS analyses and sequencing. A. lentulus was previously considered to be a variant of
A. fumigatus, but additional studies suggest that this is a unique
species (26, 32). A. lentulus has been shown to cause invasive
aspergillosis and has increased azole, amphotericin B, and caspofungin MICs, and this differentiation is clinically important (33–
35). Another study examining the ability of the Vitek MS system to
differentiate species of Aspergillus showed that the research-useonly (RUO) system is able to accurately identify the closely related
species of A. fumigatus and A. lentulus (26).
Other phenotypic misidentifications include five isolates originally identified as Paecilomyces spp. but identified as Aspergillus
sydowii (one isolate) and Rasamsonia argillacea complex (four isolates) by MALDI-TOF MS. Members of the R. argillacea complex,
previously known as Geosmithia spp., are commonly misidentified as Paecilomyces or Penicillium spp. and are a known, yet rare,
cause of human infection in immunocompromised hosts. R. argillacea has been identified as a colonizing organism in cystic fibrosis patients and as a cause of pulmonary infections. It is resistant to voriconazole, with variable resistance to itraconazole and
amphotericin B (36). Two isolates identified as Menispora spp.
were determined to be Eutypella scoparia and one isolate identified
phenotypically as Chrysosporium spp. was identified as Pseudallescheria boydii by both MALDI-TOF MS and sequencing. All four
of these organisms are environmental molds and are typically considered contaminants except for P. boydii, which has been implicated in a variety of illnesses in immunocompromised patients
and in near-drowning victims (37). Accurate identification of this
organism is important due to its decreased susceptibility to many
antifungals, including some azoles, amphotericin B, and micafungin (38).
MALDI-TOF MS for the identification of molds presents
unique challenges not encountered with other organism types,
such as bacteria and yeasts. As a result of the unique properties of
the filamentous fungi, such as robust cell walls and lower growth
rates, there have been many barriers to the development of robust
methods for MALDI-TOF MS identification. To date, a major

August 2016 Volume 54 Number 8

n, number of isolates.

limitation of MALDI-TOF MS for mold identification has been
the breadth of commercially available databases. Despite this, a
meta-analysis examining the use of MALDI-TOF MS for the identification of yeasts and filamentous fungi showed that while the
analytical performance characteristics are not as desirable as for
the yeasts, the method is able to provide accurate and rapid mold
identification (17). Of note, investigations using expanded laboratory-developed databases have returned a much higher rate of
mold identification (11, 15). Studies examining MALDI-TOF MS
for the identification of filamentous fungi have used different
MALDI-TOF MS systems, databases (both manufacturer developed and laboratory developed), and extraction protocols. This
makes it difficult to directly compare the results from different
studies. That said, our study demonstrated a challenge with Fusarium sp. identification, even with the additional SARAMIS analyses. Fusarium spp. are important pathogens, especially in immunocompromised hosts, and accurate and rapid diagnosis is
important. This challenge has not been reported in prior publications although earlier studies have evaluated different systems
and/or hardware (10, 11, 15, 39).
For the Mucorales, another group of clinically important
pathogens, our study identified only 70% of the isolates; this is
consistent with previous literature, where the rates of correct identifications for Mucor spp. and Rhizopus spp. range from 66.7% to
100% (10, 11, 15, 39). Previous studies have shown that MALDITOF MS is a rapid and accurate method for the identification of
dermatophytes. There have been many studies examining this
group of molds, with identification rates of ⬎90% for these studies (12, 13, 20–22). Our study correctly identified 100% (14/14) of
the dermatophytes tested. Finally, there have been relatively few
studies examining dimorphic fungi. For our study, we correctly
identified the two H. capsulatum and four B. dermatitidis isolates
tested.
The strength of this study is the evaluation of a large number of
unique isolates using an updated Vitek MS database. However,
this study is not without its limitations, including the facts that the
isolates evaluated are from a single medical center and that some
important species were underrepresented due to lack of available
isolates, especially the thermally dimorphic fungi. In addition, 32
of the isolates were identified using the SARAMIS database; the
ability of a laboratory to fully utilize an augmented database with
the SARAMIS database and superspectra will vary, depending on
the access of the laboratory to a bank of well-curated fungal isolates for comparison.
In summary, the Vitek MS and Knowledge Base version 3.0
library are able to accurately identify filamentous fungi isolated
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Aspergillus spp. identified
by MALDI-TOF MS

TABLE 3 Discrepant identification between phenotype and MALDITOF MS

McMullen et al.

from clinical specimens. While nearly one-fourth of the isolates
tested were not found in the database, the addition of the SARAMIS software allows the user to easily analyze and add new spectra
to the database. This feature will be a tremendous benefit for laboratories with large collections of clinical isolates. Additional
studies examining the effect of expedited mold identification on
patient outcomes are needed.
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